Is Generic Advair Good

After years of patent disputes over the blockbuster inhaler a new generic manufactured by mylan will be available in pharmacies in the coming weeks.
Is generic advair good. 100 mcg 50 mcg 250 mcg 50 mcg and 500 mcg 50 mcg. It is therapeutically equivalent to advair diskus. Vectura group plc said sales and profits for 2020 will be better than the market expects after the approval of a generic version of asthma drug advair in december.
Wixela inhub is the first approved generic version of advair diskus. On goodrx advair is currently the most popular medication in a class of drugs known as beta agonist corticosteroid combination drugs. It is also used to prevent flare ups or worsening of chronic obstructive pulmonary disease copd associated with chronic bronchitis and or emphysema.
Wixela inhub and advair diskus fluticasone propionate and salmeterol inhalation powder usp are combination products containing a corticosteroid and a long acting beta 2 adrenergic agonist indicated for. This us regulatory approval. Advair diskus is for use in adults and children who are at least 4 years old.
You have to clean it a ot and when you do the number of use goes down to 0 when it has plenty in it then you have to waste medicine using it in the air to see if there is any left this medicine is so expensive they should look in to fixing the container it comes in. Advairs generic treatment option has hit the market this truly is good news in that this product offers a 69 81 discount compared to the price of advair. Food and drug administration for chronic obstructive pulmonary.
Read more about new generic here. This medicine is very expensive they should work on new container. The fda approved the first generic version of advair diskus fluticasone salmeterol for asthma and copd on january 30 2019.
Generic fluticasone salmeterol will be available in the following three strengths. Advair does work really well but the disk spray is terrible. The first generic version of advair diskus was recently approved by the fda as a twice daily breathing maintenance therapy for copd and asthma patients.